A RANDOMIZED CONTROLLED-STUDY OF BROMOCRIPTINE VERSUS LEVODOPA IN PREVIOUSLY UNTREATED PARKINSONIAN-PATIENTS - A 3 YEAR FOLLOW-UP

被引：68

作者：

MONTASTRUC, JL

RASCOL, O

RASCOL, A

机构：

[1] PURPAN UNIV HOSP,SCH MED,DEPT MED & CLIN PHARMACOL,INSERM,U317,TOULOUSE,FRANCE

[2] PURPAN UNIV HOSP,SCH MED,DEPT NEUROL,TOULOUSE,FRANCE

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1989年 / 52卷 / 06期

关键词：

D O I：

10.1136/jnnp.52.6.773

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：773 / 775

页数：3

共 17 条

[1] CHRONIC TREATMENT WITH L-DOPA, BUT NOT BROMOCRIPTINE INDUCES DYSKINESIA IN MPTP-PARKINSONIAN MONKEYS - CORRELATION WITH [H-3] SPIPERONE BINDING [J].

BEDARD, PJ ;

DIPAOLO, T ;

FALARDEAU, P ;

BOUCHER, R .

BRAIN RESEARCH, 1986, 379 (02) :294-299

[2] ERGOT DERIVATIVES FOR PARKINSONISM [J].

CALNE, DB ;

WILLIAMS, AC ;

NUTT, JG ;

NEOPHYTIDES, A ;

EISLER, T ;

TEYCHENNE, PF .

MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 :25-26

[3]

DUVOISIN RC, 1970, MONOAMINES NOYAUX GR, P313

[4] BROMOCRIPTINE - PROBLEMS WITH LOW-DOSE DENOVO THERAPY IN PARKINSONS-DISEASE [J].

GRIMES, JD ;

DELGADO, MR .

CLINICAL NEUROPHARMACOLOGY, 1985, 8 (01) :73-77

[5] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[6] INTERNATIONAL-SYMPOSIUM ON EARLY DOPAMINE AGONIST THERAPY OF PARKINSONS-DISEASE [J].

KURLAN, R .

ARCHIVES OF NEUROLOGY, 1988, 45 (02) :204-206

[7] BROMOCRIPTINE IN PARKINSONISM - LONG-TERM STUDY [J].

LEES, AJ ;

HADDAD, S ;

SHAW, KM ;

KOHOUT, LJ ;

STERN, GM .

ARCHIVES OF NEUROLOGY, 1978, 35 (08) :503-505

[8]

LEES AJ, 1981, J NEUROL NEUROSUR PS, V44, P1021

[9]

LIBMAN I, 1987, CAN J NEUROL SCI, V14, P576

[10]

LIEBERMAN AN, 1985, PHARMACOL REV, V37, P217

← 1 2 →